Login / Signup

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.

Emily PickeringElizabeth L SteelsKathryn J SteadmanAmanda RaoLuis Vitetta
Published in: Inflammopharmacology (2022)
Registry name: Australian New Zealand Clinical Trials Registry (ANZCTR), Registration number: ACTRN12620001302943, Registration link: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380826 , Actual study start date: 20 November 2020.
Keyphrases
  • neuropathic pain
  • clinical trial
  • spinal cord
  • spinal cord injury
  • phase ii
  • phase iii
  • type diabetes
  • study protocol
  • sensitive detection
  • open label